Literature DB >> 22472851

Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan.

Tomoari Kamada1, Hiromichi Kurose, Yoshiyuki Yamanaka, Noriaki Manabe, Hiroaki Kusunoki, Akiko Shiotani, Kazuhiko Inoue, Jiro Hata, Hideo Matsumoto, Takashi Akiyama, Toshihiro Hirai, Yoshito Sadahira, Ken Haruma.   

Abstract

BACKGROUND/AIMS: The relationship between gastroesophageal junction adenocarcinoma (GEJA) and Helicobacter pylori infection is not well defined; thus, we retrospectively investigated this relationship.
METHODS: We examined 852 cases (646 men) of gastric cancer. GEJA was defined as type II according to the classification system of Siewert and Stein. We compared the prevalence of H. pylori infection and corporal gastritis in GEJA patients with distal gastric cancer.
RESULTS: GEJA was observed in 80 (including 6 cases of Barrett's esophageal cancer) of the 852 cases of gastric cancer examined (9.4%). The rate of H. pylori infection was significantly lower in patients with GEJA than in patients with distal gastric cancer (73.8 vs. 94.1%, p < 0.05). The prevalence of corporal gastritis was also significantly lower in patients with GEJA than in patients with distal gastric cancer (80.7 vs. 94.6%, p < 0.05). Concurrent H. pylori infection and corporal gastritis were not observed in patients with Barrett's esophageal cancer.
CONCLUSION: Our study demonstrated that GEJA has 2 etiologic types; one of these types is associated with H. pylori infection and resembles distal gastric cancer, and the other one is not associated with H. pylori infection or Barrett's esophageal cancer.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22472851     DOI: 10.1159/000336352

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

Review 1.  Helicobacter pylori in gastric malignancies.

Authors:  Abhishek Bhandari; Sheila E Crowe
Journal:  Curr Gastroenterol Rep       Date:  2012-12

2.  [Standards for diagnostics and therapy of gastric cancer].

Authors:  N Schulte; M Ebert
Journal:  Internist (Berl)       Date:  2014-08       Impact factor: 0.743

3.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

4.  Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.

Authors:  Jae Jin Hwang; Dong Ho Lee; Ae-Ra Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

6.  Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.

Authors:  A Shiotani; T Murao; Y Kimura; H Matsumoto; T Kamada; H Kusunoki; K Inoue; N Uedo; H Iishi; K Haruma
Journal:  Br J Cancer       Date:  2013-10-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.